Patricia Soarez

Prof. Patricia Soarez

Universidade de São Paulo - USP
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Ranjit ManchandaRanjit Manchanda
Ranjit Manchanda
LSLi Sun
Li Sun
SPShreeya Patel
Shreeya Patel
OEOlivia Evans
Olivia Evans
JWJanneke Wilschut
Janneke Wilschut
RLRosa Legood
Rosa Legood
Clinical criteria/Family history-based BRCA testing misses a large proportion of BRCA carriers who can benefit from screening/prevention. We estimate the cost-effectiveness of population-based BRCA testing in general population women across different countries/health systems. A Markov model comparing the lifetime costs and effects of BRCA1/BRCA2 testing all general population women ≥30 years compared with clinical criteria/FH-based testing. Separate analyses are undertaken for the UK/USA/Netherlands (high-income countries/HIC), China/Brazil (upper–middle income countries/UMIC) and India (low–middle income countries/LMIC) using both health system/payer and societal perspectives. BRCA carriers undergo appropriate screening/prevention interventions to reduce breast cancer (BC) and ovarian cancer (OC) risk. Outcomes include OC, BC, and additional heart disease deaths and incremental cost-effectiveness ratio (ICER)/quality-adjusted life year (QALY). Probabilistic/one-way sensitivity analyses evaluate model uncertainty. For the base case, from a societal perspective, we found that population-based BRCA testing is cost-saving in HIC (UK-ICER = $−5639/QALY; USA-ICER = $−4018/QALY; Netherlands-ICER = $−11,433/QALY), and it appears cost-effective in UMIC (China-ICER = $18,066/QALY; Brazil-ICER = $13,579/QALY), but it is not cost-effective in LMIC (India-ICER = $23,031/QALY). From a payer perspective, population-based BRCA testing is highly cost-effective in HIC (UK-ICER = $21,191/QALY, USA-ICER = $16,552/QALY, Netherlands-ICER = $25,215/QALY), and it is cost-effective in UMIC (China-ICER = $23,485/QALY, Brazil−ICER = $20,995/QALY), but it is not cost-effective in LMIC (India-ICER = $32,217/QALY). BRCA testing costs below $172/test (ICER = $19,685/QALY), which makes it cost-effective (from a societal perspective) for LMIC/India. Population-based BRCA testing can prevent an additional 2319 to 2666 BC and 327 to 449 OC cases per million women than the current clinical strategy. Findings suggest that population-based BRCA testing for countries evaluated is extremely cost-effective across HIC/UMIC health systems, is cost-saving for HIC health systems from a societal perspective, and can prevent tens of thousands more BC/OC cases.

1 November 2006 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
PDF file
RCRozana Mesquita Ciconelli
Rozana Mesquita Ciconelli
Patricia SoarezPatricia Soarez
Patricia Soarez
CKClarissa Campos Guaragna Kowalski
Clarissa Campos Guaragna Kowalski
MFMarcos Bosi Ferraz
Marcos Bosi Ferraz
CONTEXT AND OBJECTIVE: It is still difficult to measure work productivity losses caused by health problems. Despite the importance given to this issue over the last few years, most instruments for performing this task are available only in the English language. This study translated the Work Productivity and Activity Impairment _ General Health (WPAI-GH) Questionnaire into Brazilian Portuguese, adapted it cross-culturally and evaluated its reliability and validity. DESIGN AND SETTING: Cross-sectional survey to test scale reliability and validity, at São Paulo Hospital and the clinic of the Rheumatology division of Universidade Federal de São Paulo - Escola Paulista de Medicina (Unifesp-EPM). METHODS: Data were obtained from a survey that incorporated the WPAI-GH, short form-36 (SF-36) and some demographic questions. The questionnaires were administered by interview to 100 subjects. RESULTS: Descriptive statistics was used to characterize the subjects. The intraclass correlation coefficient and Cronbach's alpha were used to assess the reliability and internal consistency of the instrument. Intraclass correlation coefficients from 0.79 to 0.90 indicated good reliability. Cronbach's alpha of 0.74 indicated good internal consistency. Pearson's correlation coefficient was used to assess validity. There were significant positive relationships between the WPAI-GH and SF-36. CONCLUSION: The Brazilian Portuguese version of the WPAI-GH is a reliable and valid measurement tool and may be useful for those who seek to measure the impact on productivity of health problems among populations of Brazilian employees.

1 November 2008 in Vaccine
Verified
Journal Article
Closed access
JVJ. Valentim
J. Valentim
ASA.M.C. Sartori
A.M.C. Sartori
Patricia SoarezPatricia Soarez
Patricia Soarez
MAM. Amaku
M. Amaku
RARaymundo Soares Azevedo
Raymundo Soares Azevedo
HNH.M.D. Novaes
H.M.D. Novaes

1 January 2009 in Revista Panamericana de Salud Pública
Verified
Journal Article
Closed access
PDF file
Patricia SoarezPatricia Soarez
Patricia Soarez
ACAdauto Castelo
Adauto Castelo
PAPaulo Abrão
Paulo Abrão
WHWilliam C. Holmes
William C. Holmes
RCRozana Mesquita Ciconelli
Rozana Mesquita Ciconelli
To translate the HIV/AIDS-Targeted Quality of Life Instrument (HAT-QoL) into Brazilian Portuguese, culturally adapt it, and evaluate its psychometric properties (validity and reliability) as a Brazilian version. This cross-sectional study was carried out at the laboratory of infectious diseases at Escola Paulista de Medicina (Universidade Federal de São Paulo). Data were collected on clinical and sociodemographic characteristics of 106 HIV-infected individuals who answered the HAT-QoL and the SF-36. Pearson's correlation coefficient was used to measure construct validity. Reliability was assessed using Cronbach's alpha and intraclass correlation coefficients. The sample was 70.8% male. The mean age was 39.9 years, with 40.5% of the participants being homosexual or bisexual. Eleven (10.4%) patients had a CD4 cell count

1 January 2020 in Cadernos de Saude Publica
Verified
Journal Article
Open access
PDF file
HNHillegonda Maria Dutilh Novaes
Hillegonda Maria Dutilh Novaes
Patricia SoarezPatricia Soarez
Patricia Soarez
Avaliação de Tecnologias em Saúde: origem e desenvolvimento

20 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RXRicardo Arraes de Alencar Ximenes
Ricardo Arraes de Alencar Ximenes
CMCelina Maria Turchi Martelli
Celina Maria Turchi Martelli
MAMarcos Amaku
Marcos Amaku
ASAna Marli C. Sartori
Ana Marli C. Sartori
Patricia SoarezPatricia Soarez
Patricia Soarez
FGfor the Hepatitis Study Group
for the Hepatitis Study Group
This study aimed to identify the transmission pattern of hepatitis A (HA) infection based on a primary dataset from the Brazilian National Hepatitis Survey in a pre-vaccination context. The national survey conducted in urban areas disclosed two epidemiological scenarios with low and intermediate HA endemicity. A catalytic model of HA transmission was built based on a national seroprevalence survey (2005 to 2009). The seroprevalence data from 7,062 individuals aged 5–69 years from all the Brazilian macro-regions were included. We built up three models: fully homogeneous mixing model, with constant contact pattern; the highly assortative model and the highly assortative model with the additional component accounting for contacts with infected food/water. Curves of prevalence, force of infection (FOI) and the number of new infections with 99% confidence intervals (CIs) were compared between the intermediate (North, Northeast, Midwest and Federal District) and low (South and Southeast) endemicity areas. A contour plot was also constructed. The anti- HAV IgG seroprevalence was 68.8% (95% CI, 64.8%–72.5%) and 33.7% (95% CI, 32.4%–35.1%) for the intermediate and low endemicity areas, respectively, according to the field data analysis. The models showed that a higher force of infection was identified in the 10- to 19-year-old age cohort (∼9,000 infected individuals per year per 100,000 susceptible persons) in the intermediate endemicity area, whereas a higher force of infection occurred in the 15- to 29-year-old age cohort (∼6,000 infected individuals per year per 100,000 susceptible persons) for the other macro-regions. Our findings support the shift of Brazil toward intermediate and low endemicity levels with the shift of the risk of infection to older age groups. These estimates of HA force of infection stratified by age and endemicity levels are useful information to characterize the pre-vaccination scenario in Brazil.